EInk and Taibo cooperate with Faubel to launch smart drug label
We are a big printing company in Shenzhen China . We offer all book publications, hardcover book printing, papercover book printing, hardcover notebook, sprial book printing, saddle stiching book printing, booklet printing,packaging box, calendars, all kinds of PVC, product brochures, notes, Children's book, stickers, all kinds of special paper color printing products, game cardand so on.
For more information please visit
http://www.joyful-printing.com. ENG only
http://www.joyful-printing.net
http://www.joyful-printing.org
email: 860681365@qq.com
In late April, the world's leading e-paper leader, Eink, announced that it has launched the Faubel-MedLabel smart drug label specifically designed for experimental new drugs with Faubel & Co. Nachf. GmbH, a well-known supplier in the global pharmaceutical and chemical industries. It is reported that the smart label uses EENK's low-voltage electronic paper film technology to introduce display modules and new system designs into pharmaceutical packaging applications.
It is understood that the MedLabel smart drug label combined with electronic paper display, book label and RFID radio frequency identification technology, so that the information on the drug packaging can be updated according to needs. EInk's stable-segmented electronic paper displays the expiration date of the drug, even if the smart tag is sealed in the outer packaging. This digital solution provides pharmaceutical companies with a new alternative to relabeling drugs when the safety period of clinical trial drugs changes, significantly reducing the time and cost of international clinical trials. Innovative clinical trial supply chain.
Smart drug labeling is a breakthrough product that makes it easier to manage experimental drugs in the clinical trial supply chain. There are more and more biotech products now, and it is necessary to update the security period data frequently. The MedLabel smart drug label launched this time, in addition to being cost-effective and efficient, also meets current and future drug specifications.

